$26,500/yr for a drug that doesn't actually help a person with dementia.
How many times is the FDA going to approve beta amyloid lowering drugs that have no benefit to disease? isn't lowering beta amyoid and not affecting disease just proof, in humans, that the beta amyloid hypothesis is wrong?